Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-07-11 pm EDT 5-day change 1st Jan Change
542.7 USD +1.08% Intraday chart for Thermo Fisher Scientific +0.48% +2.24%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Thermo Fisher Scientific to Work With National Cancer Institute to Advance Research on New Treatments MT
Thermo Fisher Scientific Completes Acquisition of Olink MT
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others. CI
Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan CI
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer MT
UK Competition Watchdog Clears Thermo Fisher Scientific's Purchase of Sweden's Olink MT
UK's competition regulator clears $3.1 billion Thermo Fisher Scientific-Olink deal RE
Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating MT
Verici Dx hails milestone payment in deal with Thermo Fisher AN
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell Top 200 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000E Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth Index CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth-Defensive Index CI
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Kentucky CI
Barclays Adjusts Price Target on Thermo Fisher Scientific to $600 From $615 MT
Labguru Announces New Distribution Partnership with Thermo Fisher Scientific of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research CI
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies CI
RBC Trims Price Target on Thermo Fisher Scientific to $660 From $662, Keeps Outperform Rating MT
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Wisconsin CI
Thermo Fisher Scientific Inc., National University Hospital, Singapore and Mirxes Collaborates to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore CI
Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific CI
Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products CI
Thermo Fisher Scientific Introduces Thermo Scientific Heracell VIOS 250i AxD CO2 Incubators CI
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing MT
Chart Thermo Fisher Scientific
More charts
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
536.9 USD
Average target price
628.2 USD
Spread / Average Target
+17.01%
Consensus
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. News Thermo Fisher Scientific
  5. Thermo Fisher Scientific to Work With National Cancer Institute to Advance Research on New Treatments